{"schema_version":"secwatch.filing_event.v1","accession":"0001396814-23-000045","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2023-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.782976+00:00","generated_at":"2026-06-10T21:39:15.816935+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Pacira board rejects Gary Pace's resignation after withhold vote; plans diverse director additions","bullets":["At June 13 annual meeting, Dr. Gary Pace received more withhold than for votes in Class III director election.","Pace tendered resignation per majority-vote policy; independent directors unanimously rejected it.","Board engaged independent search firm to identify diverse candidates; expects to refresh board composition soon.","Pace will continue as Class III director until 2026 annual meeting or until successor elected."],"urls":{"canonical":"https://secwatch.observer/filing/0001396814-23-000045","json":"https://secwatch.observer/filing/0001396814-23-000045.json","markdown":"https://secwatch.observer/filing/0001396814-23-000045.md","text":"https://secwatch.observer/filing/0001396814-23-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000139681423000045/0001396814-23-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000139681423000045/pcrx-20230907.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T21:39:15.816935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}